INTEGER HOLDINGS CORP (ITGR)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for ITGR
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| ITGR | Former President and Chief Executive Officer of iRhythm Technologies, Inc.; President and CEO | 63 | ["Leadership in digital healthcare","Experience in medical device industry","Board member experience at Haemonetics Corporation","Expertise in healthcare, finance, business strategy, global operations and sales and marketing"] | ["Audit","Compensation & Organization","Technology Strategy","Compensation and Organization"] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| HAE | Director; Former President and Chief Executive Officer, iRhythm Technologies, Inc. | 64 | ["Former President and Chief Executive Officer, iRhythm Technologies, Inc.","Executive Vice President and Group President, Cardiac and Vascular Group of Medtronic plc","Former President of the Cardiac Rhythm Management division at St. Jude Medical Inc.","Leadership positions at St. Jude and Eli Lilly & Company","Holds six U.S. patents related to cardiovascular medical device products and technologies"] | ["Audit Committee","Technology Committee","Audit","Technology"] | 2026 |
| IRTC | Former President and Chief Executive Officer | 60 | [] | [] | 2022 |
Biography sourced from the proxy statement filing.
S Medical Technologies, Inc. and Volcano Corporation. He holds six U.S. patents related to cardiovascular medical device technologies. Mr. Coyle s decades of senior leadership experience in the medical device industry, including leading global businesses and overseeing complex commercial and operational organizations, bring significant value to the Board. His expertise in healthcare, finance, business strategy, global operations and sales and marketing supports the Board s oversight of the Company s strategic growth, financial discipline and global operating model. Age: 63 Director Since: 2025 Integer Committees: Audit Compensation and Organization Technology Strategy